SecSonar.com

Bruker Corporation (BRKR)

Bruker Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Bruker Corporation (BRKR) is a Medical - Devices company based in US with a market capitalization of $8.8B. Revenue grew 2.1% year-over-year and the company generated $43.3M in free cash flow. This page tracks BRKR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 11.4K employees · IPO Aug 4, 2000

Valuation

Valuation & price

$42.88 · as of May 17, 2026 · -31.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.58

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$59.97$44.66$29.35Jul 25Dec 25Jun 26Jul 7, 25$41.27Jul 9, 25$42.12Jul 11, 25$43.79Jul 15, 25$41.96Jul 17, 25$42.19Jul 21, 25$35.64Jul 23, 25$39.91Jul 25, 25$41.94Jul 29, 25$42.05Jul 31, 25$38.43Aug 4, 25$34.72Aug 6, 25$30.66Aug 8, 25$30.43Aug 12, 25$32.36Aug 14, 25$33.64Aug 18, 25$34.24Aug 20, 25$33.73Aug 22, 25$35.54Aug 27, 25$33.59Aug 29, 25$33.98Sep 3, 25$29.35Sep 5, 25$30.83Sep 9, 25$31.18Sep 11, 25$32.07Sep 15, 25$32.07Sep 17, 25$32.11Sep 19, 25$33.17Sep 23, 25$33.31Sep 25, 25$30.78Sep 29, 25$30.88Oct 1, 25$34.72Oct 3, 25$36.98Oct 7, 25$34.56Oct 9, 25$35.93Oct 13, 25$36.23Oct 16, 25$38.20Oct 20, 25$38.11Oct 22, 25$38.95Oct 24, 25$39.00Oct 28, 25$38.72Oct 30, 25$36.40Nov 3, 25$38.71Nov 5, 25$40.20Nov 7, 25$39.93Nov 11, 25$41.73Nov 13, 25$41.79Nov 17, 25$41.77Nov 19, 25$43.39Nov 21, 25$47.27Nov 25, 25$49.33Nov 28, 25$48.81Dec 2, 25$47.29Dec 5, 25$48.03Dec 9, 25$45.36Dec 11, 25$46.37Dec 15, 25$45.67Dec 17, 25$44.41Dec 19, 25$46.48Dec 23, 25$48.02Dec 26, 25$48.01Dec 30, 25$47.51Jan 2, 26$48.11Jan 6, 26$52.67Jan 8, 26$52.48Jan 12, 26$53.41Jan 14, 26$49.14Jan 16, 26$48.39Jan 21, 26$51.95Jan 23, 26$50.33Jan 28, 26$46.55Jan 30, 26$44.29Feb 3, 26$42.66Feb 5, 26$41.04Feb 9, 26$42.10Feb 11, 26$42.43Feb 13, 26$36.51Feb 18, 26$39.76Feb 20, 26$38.28Feb 24, 26$39.77Feb 26, 26$41.02Mar 2, 26$39.81Mar 4, 26$38.50Mar 6, 26$36.68Mar 10, 26$36.60Mar 12, 26$35.05Mar 16, 26$32.76Mar 19, 26$33.63Mar 23, 26$34.86Mar 25, 26$35.80Mar 27, 26$33.72Mar 31, 26$36.12Apr 2, 26$36.76Apr 7, 26$36.67Apr 9, 26$37.98Apr 13, 26$39.05Apr 15, 26$39.48Apr 17, 26$40.70Apr 21, 26$40.09Apr 23, 26$36.22Apr 27, 26$36.53Apr 29, 26$34.29May 1, 26$36.79May 5, 26$38.01May 8, 26$44.16May 12, 26$44.73May 14, 26$44.16May 18, 26$42.75May 20, 26$44.26May 22, 26$45.69May 27, 26$48.62May 29, 26$58.89Jun 2, 26$57.31Jun 4, 26$59.97Jun 8, 26$56.26Jun 10, 26$54.92Jun 12, 26$54.23Jun 16, 26$55.80Jun 18, 26$57.23Jun 23, 26$55.11Jun 29, 26$59.42
$29.3552-week range$62.70
Loading valuation history…

Fundamentals

Key fundamentals

$8.8B

Market cap

2.1%

Revenue growth (YoY)

45.9%

Gross margin

$43.3M

Free cash flow (USD)

$1.7B

Net debt

1.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.6BFY 2017$1.8BFY 2018$1.9BFY 2019$2.1BFY 2020$2.0BFY 2021$2.4BFY 2022$2.5BFY 2023$3.0BFY 2024$3.4BFY 2025$3.4B
$1.6B$3.4B

Free cash flow by year

2016 → 2025

FY 2016$93.7MFY 2017$110.7MFY 2018$190.5MFY 2019$140.4MFY 2020$235.0MFY 2021$190.4MFY 2022$145.2MFY 2023$243.2MFY 2024$136.0MFY 2025$43.3M
$93.7M$43.3M

Gross margin by year

2021 → 2025

FY 202150.0%FY 202251.6%FY 202351.0%FY 202449.0%FY 202545.9%
50.0%45.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • FinancingSecurities RegistrationJun 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 21, 2026Filing
  • 8-K eventDividend DeclaredMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • 8-K eventDividend DeclaredApr 28, 2026Filing
  • 8-K eventExecutive DepartureApr 10, 2026Filing
  • 8-K eventDirector AppointmentApr 1, 2026Filing

Questions

Frequently asked questions

What is Bruker Corporation's market cap?

Bruker Corporation (BRKR) has a market capitalization of $8.8B.

What is BRKR's P/E ratio?

A meaningful P/E ratio is not available for BRKR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BRKR's price-to-book (P/B) ratio?

BRKR trades at 3.58 times book value per share.

Are insiders buying BRKR stock?

SEC Form 4 filings show no open-market insider buys at Bruker Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

BIO

Bio-Rad Laboratories, Inc.

$8.5B

MASI

Masimo Corporation

$9.3B

PODD

Insulet Corporation

$9.9B

GMED

Globus Medical, Inc.

$11.1B

GKOS

Glaukos Corporation

$6.1B

PEN

Penumbra, Inc.

$12.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.